Med Spa Business Plan: The Numbers Section Most Templates Skip

Most med spa business plans nail the structure and hand-wave the money. The executive summary, the market analysis, the services list — most templates cover those well. Then they reach the financials and shrink it to a startup-cost range and a promise that you'll "break even in as little as 3–9 months." But the section that actually decides whether you survive is the one they skip: what each treatment costs you, what it earns, how many you need to sell, and how prepaid memberships quietly turn into a liability. Here is that section — the unit economics — built on numbers you can actually source.

What every template gets right — and where they stop

Give the standard med spa business plan its due. The outline is genuinely useful and you should write all of it:

• Executive summary, market analysis, and services — what you offer and to whom.
• Ownership, staffing, and the medical director — the compliance backbone of an aesthetic practice.
• Marketing and operations — how patients find you and what happens when they arrive.
• A startup-cost range — usually a single band like "$200K–$500K."

Where they stop is usually the same place. They give you a cost range and a break-even timeline, and they call that the financial plan. But a range isn't a model, and a timeline isn't a calculation — it's a guess someone else made about a business that isn't yours. What's missing is the arithmetic that connects the two: the cost of one Botox appointment, the margin left after product, and the monthly revenue that actually covers your fixed costs. That arithmetic is below.

The market numbers — and which ones are real

Start with an honest read of the industry, because this is where the exaggeration begins. The measured numbers — from the American Med Spa Association's own State of the Industry summary — look like this:

Those are real, published averages, and they're the ones to build a plan against. The trouble starts when the bigger, rounder numbers get borrowed as if they mean the same thing.

None of this makes the opportunity smaller — the count grew by more than 1,500 spas in a single year and 18% of them were brand-new in 2023. It just means your plan should anchor on the measured $1.4M and $527, not on a headline that quietly changed the subject.

The numbers section templates skip: your unit economics

Here's the part most templates skip. A med spa isn't one business — it's four or five little ones stacked together, each with completely different economics. You can't plan it with a single "margin %." You have to start at the level of a single treatment.

Step one: cost per treatment, not revenue

Before you can price anything, you need the variable product cost — what leaves your inventory every time you perform the service. For injectables that number is knowable:

• Neurotoxin (Botox and friends). AbbVie's public list price (WAC) is about $656 per 100-unit vial — roughly $6.56 a unit. In practice, low-volume providers pay $500–$600 a vial and high-volume chains negotiate toward $300–$400, so your real cost lands around $4–$6 per unit. A 20-unit glabellar treatment is therefore about $80–$120 in product, plus reconstitution supplies and injector time.
• Dermal filler. Wholesale is roughly $250–$400 per syringe (approximate and brand-dependent), against a retail price that usually runs $600–$1,200 — around $750 on average. Higher revenue per appointment than neurotoxin, but a lower margin and a longer repeat cycle — 6–12 months versus 3–4 for a toxin.
• Laser and energy devices. Once the machine is paid off, the marginal product cost is close to zero — the highest incremental margin in the building. The catch is that the device itself is a large fixed cost you carry whether or not it's booked.
• Retail skincare. A straightforward wholesale-to-retail markup, minimal clinical time — low margin percentage, but almost no cost to deliver.

Every one of those product-cost figures is a range on purpose. Your negotiated pricing, your local retail rates, and your volume will move them. That's exactly why a plan needs your inputs, not a borrowed benchmark.

Step two: contribution margin, per service line

Now subtract product cost from price and you get contribution margin — the money each treatment leaves behind to cover rent, payroll and the medical director. Do it separately for each line, because they don't behave alike:

Illustrative, using public list and wholesale prices — your negotiated costs and local pricing will differ. Prices exclude injector time and overhead, which contribution margin is meant to cover.

The lesson of the table is the whole point of the section: a plan that folds neurotoxin, filler, lasers and retail into one blended margin is hiding the thing that determines whether it works. A toxin-led spa and a device-led spa are different companies with different break-evens.

Break-even is a formula, not a promise

Templates love to promise you'll break even in as little as 3–9 months — a number no dataset supports, because break-even isn't a fact about the industry. It's a fact about your fixed costs and your margins, and it comes out of one equation:

Fixed opex is everything you owe whether or not a single patient books — and it's where the med-spa-specific line most templates forget lives:

• Rent — commonly $3,000–$7,000 a month, higher in dense metros.
• Base payroll — front desk, an aesthetician, an injector's base.
• Medical director retainer — roughly $1,000–$5,000 a month ($12,000–$60,000 a year). An aesthetic practice needs supervising-physician oversight, and generic business-plan templates leave this line out entirely.
• Software, insurance, and a marketing baseline — the steady spend to keep the lights on and the calendar full.

Put numbers to it. Say your fixed opex lands near $30,000 a month and your blended contribution margin — weighted across your mix — is about 70%. Then break-even revenue is $30,000 ÷ 0.70 ≈ $42,900 a month, which at the $527 average visit is roughly 81 visits a month — well under the ~245 an established location averages, but a real hill to climb from a standing start. Change the inputs and the answer moves; that's the point. Plan on being cash-flow negative for the first several months and recouping your capex over two to four years, but compute your own version instead of trusting a promised date. (The $30K and 70% here are placeholders to show the arithmetic — replace them with your quotes.)

The line every plan gets wrong: prepaid memberships

Memberships and prepaid packages are the med spa's best friend and a common, costly accounting mistake. On the upside, recurring plans smooth out revenue and pull clients back — and retention matters here more than almost anywhere, given that repeat clients are already 73% of the average spa's visits. Consultants estimate memberships can reach 20–30% of a mature spa's revenue; treat that as an informed target rather than a measured fact, but the direction is right.

Here's the trap. Prepaid money is a liability, not revenue — until you deliver the treatment. When a client buys a $1,200 package, that isn't $1,200 of revenue this month; it's $1,200 of obligation you'll recognize a slice at a time as she redeems visits. Book it all as earned on the day it's sold and a strong sales month looks wildly profitable, your margins look better than they are, and you spend against cash you still owe in services. Getting this one line right — deferred revenue recognized on delivery — is what separates a plan that survives contact with reality from one that flatters you until the packages come due.

From plan targets to the numbers you'll track

Everything above is target-setting: the margins you intend to hold, the visits you need, the membership mix you're aiming for. The moment you open, those targets become questions you have to answer with real data — and that's a different job from writing the plan.

Two of these are worth planning for specifically because they leak the most money quietly: an empty chair earns nothing, so a rising no-show rate erases margin you already budgeted, and slipping retention quietly raises what you must spend to fill the calendar. Write targets for both into the plan, then watch them from day one.

Frequently asked questions

Written by

Olha · clinic data analyst

I build the reporting our managers open every morning at a multi-branch medical clinic — and package it so other practices and med spas don't have to start from scratch.

Dollar figures here are labelled by what they are — an association survey (AmSpa), a manufacturer list price (AbbVie's WAC), a market-research model, or a vendor-consultant consensus range — with the scope and year noted. AmSpa's granular revenue-mix and margin figures (including the quoted 27.6% EBITDA) sit behind its paid report and are attributed, not independently verified; the often-cited ~$2M average is AmSpa's own superseded earlier figure, not a current benchmark. Product costs are approximate and volume-dependent. Where a widely-quoted number has no traceable source, we say so rather than repeat it.